Dr. Armon Sharei, Ph.D. is the Founder of SQZ Biotechnologies Company and serves as its Chief Executive Officer since January 2015. He is Fellow of Harvard Medical School and holds a B.S. with Honors and Distinction from Stanford University and a PhD from MIT. Dr. Sharei work has been highlighted by numerous news outlets including Nature, Nature Methods, New Scientist, and the National Institute of Health.
From 2008 to 2013, Armon pursued his PhD in Chemical Engineering under Klavs Jensen and Robert Langer at the MIT. His methods for disrupting cell membranes formed the foundation of SQZ Biotech in 2013. Co-founded with Jensen and Langer, the company aims to use the squeeze mechanism to power cells to fight diseases, including cancer and autoimmune diseases.
The idea has been met with wide excitement. In 2014, Scientific American featured it as one of the year’s Top 10 World Changing ideas. The following year, Fierce Biotech ranked SQZ amongst fifteen world-changing biotech companies. They raised $1 million in seed funding in 2014, followed by $5 million in 2015 and closed Series-B funding in September 2016, raising $16 million in a round led by NanoDimension and Polaris Partners.